BioSpace News Archive

Lone Star Bio

Nanoscope’s Vision Restoring Optogenetic Gene Therapy to be Featured in Four Presentations as part of SPIE Photonics West 2022 in San Francisco Jan. 22-27, 2022

Nanoscope Therapeutics Inc., will be featured in several presentations at BiOS, the world’s largest biomedical optics and biophotonics conference, as a part of SPIE Photonics West 2022, in San Francisco, January 22–27, 2022 at the Moscone Center.

January 19, 2022
·
2 min read
Slide Stainers Market Size To Reach USD 8.02 Billion By 2028, Says Reports And Data

Technological advancements in laboratory infrastructure and surging demand for laboratory automation solutions is bolstering market growth.

January 19, 2022
·
7 min read
Molecular Imaging Market Size to Reach USD 11.27 Billion in 2028 | Industry Trend – Technological advances in molecular imaging techniques

According to Emergen Research, the global molecular imaging market size was USD 7,432.81 million in 2020 and is expected to reach USD 11.27 billion in 2028 and register a revenue CAGR of 5.3% during the forecast period, 2021-2028.

January 19, 2022
·
8 min read
Tissue Engineering Market Trend – Technological advances in tissue engineering, such as 3D bio-printing

Revenue growth of the global tissue engineering market is majorly supported by factors such as rising prevalence of chronic diseases including diabetes and obesity, increasing incidences lifestyle diseases, rapidly growing geriatric population, and increasing cases of trauma emergencies.

January 19, 2022
·
8 min read
Lonza Drug Product Services Participates in the RealHOPE Project to Assess and Improve Protein Stability

Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, announced today that its Drug Product Services is participating in the Real-World Handling of Protein Drugs - Exploration, Evaluation and Education (RealHOPE) project.

January 19, 2022
·
5 min read
BioCapital

Myth vs. Fact: CMS Draft Decision on Alzheimer’s Drugs

With so much misinformation surrounding the draft National Coverage Determination (NCD) from the Centers for Medicare and Medicaid Services (CMS) not to cover the first class of Alzheimer’s drugs, except in very limited circumstances, UsAgainstAlzheimer’s is setting the record straight.

January 19, 2022
·
2 min read
Liminal BioSciences Announces Strategic Priorities For 2022

Liminal BioSciences Inc., provided an update in which it outlined key corporate and research and development priorities for 2022.

January 19, 2022
·
8 min read
Biotech Beach

Ensysce Biosciences Reminds Stockholders to Vote at Upcoming Special Meeting

Ensysce Biosciences, Inc., a clinical-stage biotech company with novel technology platforms that may provide new hope for those in severe pain, reminded stockholders to vote at the upcoming special meeting of stockholders to be held on January 26, 2022 at 12:00 pm ET.

January 19, 2022
·
4 min read
Business

Envista Schedules Fourth Quarter 2021 Earnings Call

Envista Holdings Corporation will report financial results for its fourth quarter 2021 on Wednesday, February 9, 2022.

January 19, 2022
·
2 min read
Policy

Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Pancreatic Cancer

Marker Therapeutics, Inc. announced that the United States Food and Drug Administration Office of Orphan Products Development has granted Orphan Drug designation to MT-601, a multi-tumor-associated antigen -specific T cell product optimized for the treatment of patients with pancreatic cancer.

January 19, 2022
·
3 min read